GLS-5310 Vaccine in Healthy Volunteers for the Prevention of SARS-CoV-2 (COVID-19)

First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects

NCT04893512 ·Status: COMPLETED ·Phase: PHASE1

Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers

NCT05148962 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

NCT05394012 ·Status: UNKNOWN ·Phase: PHASE1

Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above

NCT05408312 ·Status: COMPLETED ·Phase: PHASE1

Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)

NCT05435027 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806

NCT01801293 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines

NCT05067946 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)

NCT01756482 ·Status: COMPLETED ·Phase: PHASE2

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.

NCT05354089 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine

NCT05313035 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals

NCT04915989 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of COVID19 Vaccine on the Market

NCT05890521 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2102 in Healthy Adult

NCT06313697 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

NCT07089706 ·Status: RECRUITING ·Phase: PHASE4

Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

NCT04530656 ·Status: COMPLETED ·Phase: PHASE1

GLS-5700 in Dengue Virus Seropositive Adults

NCT02887482 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

NCT05396573 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

NCT05997290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity

NCT05239832 ·Status: UNKNOWN ·Phase: PHASE2

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects

NCT05977101 ·Status: UNKNOWN ·Phase: NA

Study of COVID-19 DNA Vaccine (AG0302-COVID19)

NCT04527081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Tolerability of Regeneron Anti-SARS-CoV-2 Monoclonal Antibody/Ies in Adult Healthy Volunteers as Related to COVID-19

NCT05293678 ·Status: COMPLETED ·Phase: PHASE1

COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay

NCT04452318 ·Status: COMPLETED ·Phase: PHASE3

A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001

NCT05125926 ·Status: UNKNOWN ·Phase: PHASE1